Arcutis Biotherapeutics, Inc. (ARQT)
25.55
-1.45
(-5.37%)
USD |
NASDAQ |
Nov 06, 16:00
25.56
+0.01
(+0.04%)
After-Hours: 20:00
Arcutis Biotherapeutics Total Long Term Debt (Quarterly) : 114.62M for Sept. 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 114.62M |
| June 30, 2026 | 114.14M |
| March 31, 2026 | 114.67M |
| December 31, 2025 | 114.22M |
| September 30, 2025 | 113.77M |
| June 30, 2025 | 110.16M |
| March 31, 2025 | 109.96M |
| December 31, 2024 | 109.76M |
| September 30, 2024 | 207.38M |
| June 30, 2024 | 206.79M |
| March 31, 2024 | 205.98M |
| December 31, 2023 | 205.18M |
| September 30, 2023 | 204.35M |
| June 30, 2023 | 203.52M |
| March 31, 2023 | 202.70M |
| December 31, 2022 | 201.89M |
| September 30, 2022 | 201.04M |
| Date | Value |
|---|---|
| June 30, 2022 | 77.59M |
| March 31, 2022 | 77.36M |
| December 31, 2021 | 77.12M |
| September 30, 2021 | 4.924M |
| June 30, 2021 | 5.032M |
| March 31, 2021 | 5.05M |
| December 31, 2020 | 4.964M |
| September 30, 2020 | 3.675M |
| June 30, 2020 | 3.61M |
| March 31, 2020 | 0.082M |
| December 31, 2019 | 0.129M |
| September 30, 2019 | 0.175M |
| June 30, 2019 | 0.22M |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 57.32M |
| ADMA Biologics, Inc. | 201.62M |
| Alnylam Pharmaceuticals, Inc. | 2.951B |
| Anika Therapeutics, Inc. | 24.56M |
| Savara, Inc. | 30.11M |